A federal court judge has extended an injunction that blocked a competitor to Irvine-based Allergan Inc.’s flagship Botox after allegations that trade secrets were stolen.

U.S. District Judge Andrew Guilford in Santa Ana has entered an order against Merz Aesthetics, a U.S. unit of Germany’s Merz Pharma GmbH. The move means that a previous order prohibiting Merz from selling or soliciting purchase of its Xeomin drug for cosmetic use in the U.S. will remain in place until January 9, 2013.

Get the latest OC business updates for FREE